Becker's Healthcare January 10, 2024
CMS uses star ratings to determine the quality of Medicare Advantage and Part D prescription drug plans. The agency may terminate a plan sponsor’s contract to administer Medicare benefits if it achieves a rating of less than three stars for three consecutive contract years.
Health plans have the opportunity to appeal CMS’ decision.
Four MA contracts being terminated by CMS for low star ratings:
CMS is terminating Chicago-based Zing Health‘s Medicare Advantage prescription drug plan at the end of 2024. Zing was founded by Health2047, a venture fund from the American Medical Association. The agency is also imposing intermediate sanctions to suspend all enrollment and marketing activities for the plan, effective Jan. 12. The Part D plan has...
Today's Sponsors
Today's Sponsor